title: Optimizing the management of differentiated thyroid cancer.
authors.forename: U K
authors.initials: UK
authors.lastname: Mallick
authors.forename: H
authors.initials: H
authors.lastname: Lucraft
authors.forename: G
authors.initials: G
authors.lastname: Proud
authors.forename: P
authors.initials: P
authors.lastname: Perros
authors.forename: J
authors.initials: J
authors.lastname: Fenwick
authors.forename: P
authors.initials: P
authors.lastname: Kendall-Taylor
authors.forename: S
authors.initials: S
authors.lastname: Johnson
authors.forename: T
authors.initials: T
authors.lastname: Lennard
authors.forename: S
authors.initials: S
authors.lastname: Ball
authors.forename: R A
authors.initials: RA
authors.lastname: James
authors.forename: F
authors.initials: F
authors.lastname: Douglas
authors.forename: D R
authors.initials: DR
authors.lastname: Weightman
mesh_terms: D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D019583:Dose Fractionation, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes